Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Peer Review reports

Original Submission
24 Feb 2012	Submitted	Original manuscript
16 Mar 2012	Reviewed	Reviewer Report - Mark Jit
23 Mar 2012	Reviewed	Reviewer Report - Iacopo Baussano
30 Jul 2012	Author responded	Author comments - Michele Kohli
Resubmission - Version 2
30 Jul 2012	Submitted	Manuscript version 2
14 Aug 2012	Reviewed	Reviewer Report - Mark Jit
22 Aug 2012	Reviewed	Reviewer Report - Iacopo Baussano
2 Oct 2012	Author responded	Author comments - Michele Kohli
Resubmission - Version 3
2 Oct 2012	Submitted	Manuscript version 3
Publishing
8 Oct 2012	Editorially accepted
13 Oct 2012	Article published	10.1186/1471-2458-12-872

Back to article page